Therefore, agents capable of repressing the expression of HSP chaperones, like HSF1 inhibitors, are of particular interest for cancer therapy, as many tumors are known to highly rely on the chaperonic apparatus and express elevated levels of HSPs. The gene discussed is HSP90B2P; the disease is cancer.